Commerce Impacts Access to ‘Artificial Pancreas’ for US Patients

One insulin-pump manufacturer exits North American market as the maker of the so-called "artificial pancreas" struggles to meet demand while battling an insurer for coverage of its newest technology
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply